Terminated PHASE2 INTERVENTIONAL NCT00305331

Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease

Phase II Clinical Trial of Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease

Sponsor: University Health Network, Toronto

Conditions Parkinson's Disease Peripheral Edema

Interventions Domperidone (drug)

Updated 5 times since 2017 Last updated: Jul 26, 2012 Started: Mar 31, 2006 Primary completion: Jul 31, 2008 Completion: Sep 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

lack of recruitment

Other terminated trials from University Health Network, Toronto

See all terminations from University Health Network, Toronto

Other Parkinson's Disease trials with similar outcome

Browse all Parkinson's Disease trials

This PHASE2 trial investigates Parkinson's Disease and Peripheral Edema and is currently terminated or withdrawn. University Health Network, Toronto leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Health Network, Toronto

Data source: University Health Network, Toronto

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada